Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston's Watchman approval on knife edge as panel vote nears

This article was originally published in Clinica

Executive Summary

It has been a long road, but US approval of Boston Scientific’s Watchman stroke-prevention device for atrial fibrillation patients is still far from assured. The left atrial appendage (LAA) closure device is due to be reviewed by an FDA advisory panel on 11 December, and the agency has put out briefing documents that are decidedly mixed, raising doubts over its eventual approval.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel